Mesalazine 1.2 TAKEDA  (mesalazine) 1.2 g  prolonged release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mesalazine 1.2 takeda (mesalazine) 1.2 g prolonged release tablet blister pack

takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.

ALUNBRIG 30 MG Israel - English - Ministry of Health

alunbrig 30 mg

takeda israel ltd - brigatinib - film coated tablets - brigatinib 30 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)

ALUNBRIG 90 MG Israel - English - Ministry of Health

alunbrig 90 mg

takeda israel ltd - brigatinib - film coated tablets - brigatinib 90 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)

HUMAN ALBUMIN TAKEDA 200 MGML SOLUTION FOR INFUSION Israel - English - Ministry of Health

human albumin takeda 200 mgml solution for infusion

takeda israel ltd - albumin human - solution for infusion - albumin human 200 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

HUMAN ALBUMIN TAKEDA 50 MGML SOLUTION FOR INFUSION Israel - English - Ministry of Health

human albumin takeda 50 mgml solution for infusion

takeda israel ltd - albumin human - solution for infusion - albumin human 50 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Pantecta Control European Union - English - EMA (European Medicines Agency)

pantecta control

takeda gmbh - pantoprazole - gastroesophageal reflux - proton pump inhibitors - short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.